2 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Advanced Bladder Cancer: new trials by email Literature Review of Advanced Bladder Cancer trials Research Report on Advanced Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer enfortumab vedotin and pembrolizumab (EV/P) - Advanced Bladder Cancer | Phase 3 | Not yet recruiting | Guliz Ozgun | 224 | 2026-11-01 | 2026-10-01 |
| A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer Ex Vivo Expanded γδ T Cell Infusion - Advanced Bladder Cancer | Not yet recruiting | Shanghai 10th People's Hospital | 20 | 2025-09-26 | 2025-10-02 | |
| Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE) Enfortumab Vedotin, Radiation Therapy - Advanced Bladder Cancer | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 41 | 2024-10-10 | 2026-06-15 |
enfortumab vedotin (2) · Radiotherapy (1) · pembrolizumab (1)
Guliz Ozgun (1) · M.D. Anderson Cancer Center (1) · Shanghai 10th People's Hospital (1)
Canada (1) · United States (1)